WorldPingThe latest orphan drug exemptions may not be warranted, analysis finds
A new analysis questions the wisdom of a controversial provision in federal law that exempts so-called orphan drugs from Medicare pricing negotiations.
Brief by WorldPing · Original reporting by STAT



